Location History:
- Melbourne, AU (2022)
- Caulfield South, AU (2021 - 2023)
Company Filing History:
4 out of 371 
1 out of 24 Years Active: 2021-2024
Title: David Andrew Jans: Innovator in Viral Inhibition
Introduction
David Andrew Jans is a notable inventor based in Caulfield South, Australia. He has made significant contributions to the field of viral inhibition, holding a total of four patents. His work focuses on innovative methods to treat and prevent viral infections, particularly those caused by flaviviruses and Chikungunya virus.
Latest Patents
One of his latest patents is a method of viral inhibition that relates to treating or preventing infections caused by flaviviruses, such as dengue virus, yellow fever virus, West Nile virus, and Japanese encephalitis virus. This invention also addresses infections caused by Chikungunya virus (CHIKV). The methods involve administering retinoic acid analogues to subjects who have, are suspected of having, or are at risk of becoming infected with these viruses.
Career Highlights
Throughout his career, David Andrew Jans has worked with esteemed institutions, including Beijing University of Technology and Melbourne Health. His experience in these organizations has allowed him to develop and refine his innovative approaches to viral treatment.
Collaborations
David has collaborated with notable professionals in his field, including Kylie Michelle Wagstaff and Johanna Elisabeth Fraser. These collaborations have contributed to the advancement of his research and the successful development of his patents.
Conclusion
David Andrew Jans is a prominent figure in the realm of viral inhibition,